NanoString to Present at the Evercore ISI 2nd Annual HealthCONx Conference
SEATTLE--(BUSINESS WIRE)--Nov 25, 2019--
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management is scheduled to present at the Evercore ISI 2 nd Annual HealthCONx Conference in Boston.
Brad Gray, president and chief executive officer, is scheduled to present on Wednesday, December 4th, 2019 from 2:00-2:40pm ET. Interested parties can access the live webcast with accompanying slides from the investor section of the company’s website at www.nanostring.com. The webcast replay will be available one hour after the conclusion of the live presentation and archived for 60 days.
About NanoString Technologies, Inc.
NanoString Technologies is a leading provider of life science tools for translational research and molecular diagnostic products. The company’s nCounter® Analysis System is used in life sciences research and has been cited in more than 2,800 peer-reviewed publications. The nCounter Analysis System offers a cost-effective way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision, facilitating a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. The company’s GeoMx™ Digital Spatial Profiler enables highly-multiplexed spatial profiling of RNA and protein targets in a variety of sample types, including FFPE tissue sections. The company’s technology is also being used in diagnostics. The Prosigna® Breast Cancer Prognostic Gene Signature Assay together with the nCounter Dx Analysis System is FDA 510(k) cleared for use as a prognostic indicator for distant recurrence of breast cancer.
For more information, please visit www.nanostring.com.
NanoString, NanoString Technologies, the NanoString logo, nCounter and Prosigna are trademarks or registered trademarks of NanoString Technologies, Inc. in various jurisdictions.
View source version on businesswire.com:https://www.businesswire.com/news/home/20191125005730/en/
CONTACT: Doug Farrell
Vice President, Investor Relations & Corporate Communications
KEYWORD: WASHINGTON MASSACHUSETTS UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: SCIENCE OTHER SCIENCE RESEARCH ONCOLOGY HEALTH MEDICAL DEVICES TECHNOLOGY OTHER TECHNOLOGY
SOURCE: NanoString Technologies, Inc.
Copyright Business Wire 2019.
PUB: 11/25/2019 04:01 PM/DISC: 11/25/2019 04:01 PM